Gockley Allison, Wright Alexi
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Medicine, Brigham and Women's Hospital, ASB1, 3rd Floor, 75 Francis Street, Boston, MA 02115, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA.
Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA; Dana-Farber Cancer Institute, Susan F. Smith Center for Women's Cancers, 450 Brookline Avenue, Boston, MA 02115, USA.
Hematol Oncol Clin North Am. 2018 Dec;32(6):1073-1085. doi: 10.1016/j.hoc.2018.07.009.
Toxicities during chemotherapy for patients with ovarian cancer who present with advanced-stage disease are frequent and diverse. This review aims to describe common toxicities and management strategies for classic cytotoxic treatments and to briefly discuss the current understanding of toxicities associated with targeted therapies.
